You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Gilead Sciences

Showing 1 - 25 of 1,766
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV, Inpatient Facility Diagnoses Trial (Team Based Inpatient ARTAS, Standard of Care)

Not yet recruiting
  • HIV Infections
  • Inpatient Facility Diagnoses
  • Team Based Inpatient ARTAS
  • Standard of Care
  • (no location specified)
May 18, 2023

Esophagogastric Adenocarcinoma Trial (Sacituzumab govitecan)

Not yet recruiting
  • Esophagogastric Adenocarcinoma
  • Sacituzumab govitecan
  • (no location specified)
Nov 9, 2023

Gastrointestinal Cancer Trial (Capecitabine, Sacituzumab govetican)

Not yet recruiting
  • Gastrointestinal Cancer
  • (no location specified)
Oct 2, 2023

HIV Prevention, PrEP Awareness, PrEP Uptake Trial (A chatbot designed to promote PrEP awareness and uptake for Black MSM,

Not yet recruiting
  • HIV Prevention
  • +2 more
  • A chatbot designed to promote PrEP awareness and uptake for Black MSM
  • General educational messages
  • (no location specified)
Jul 27, 2023

Express Testing and Same-day Initiation of PrEP Study

Recruiting
  • HIV Prevention
  • Toronto, Ontario, Canada
    HQ Toronto
Jan 26, 2023

Gland, Salivary Gland Cancers Trial in Houston (Sacituzumab Govitecan)

Not yet recruiting
  • Gland
  • Salivary Gland Cancers
  • Sacituzumab Govitecan
  • Houston, Texas
    M D Anderson Cancer Center
May 22, 2023

Cervical Cancer Trial (Sacituzumab Govitecan)

Not yet recruiting
  • Cervical Cancer
  • Sacituzumab Govitecan
  • (no location specified)
Apr 18, 2023

Triple Negative Breast Cancer Trial (Sacituzumab govitecan, Pembrolizumab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • (no location specified)
Oct 5, 2023

Hepatitis C Screening Alerts

Enrolling by invitation
  • Hepatitis C
  • Hepatitis C Screening Alerts in CHORUS™
  • Standard of Care
  • Los Angeles, California
    AIDS Healthcare Foundation
Jan 24, 2023

Hepatitis C Diagnosis to Treatment Management

Enrolling by invitation
  • Hepatitis C
  • Hepatitis C Treatment Alerts in CHORUS™
  • Standard of Care
  • Los Angeles, California
    AIDS Healthcare Foundation
Feb 2, 2023

HIV Trial in New Haven (EPIC-P)

Active, not recruiting
  • HIV
  • EPIC-P
  • New Haven, Connecticut
    Storefront
Sep 2, 2022

Breast Cancer, Prostate Cancer Trial in Cleveland (NAVAH)

Not yet recruiting
  • Breast Cancer
  • Prostate Cancer
  • NAVAH
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jul 28, 2023

Cryptococcal Meningitis Trial in Kampala (Single dose liposomal Amphotericin and Fluconazole, Fluconazole)

Recruiting
  • Cryptococcal Meningitis
  • Single dose liposomal Amphotericin and Fluconazole
  • Fluconazole
  • Kampala, Uganda
    infectious Disease Institute Kampala,Uganda
Dec 21, 2022

Breast Cancer Trial (Early Point-of-Service Social and Behavioral Determinants of Health (SBDOH) Screening)

Not yet recruiting
  • Breast Cancer
  • Early Point-of-Service Social and Behavioral Determinants of Health (SBDOH) Screening
  • (no location specified)
Sep 5, 2023

HIV Trial in Thika (co-formulated 25mg TAF/ 200mg FTC)

Recruiting
  • HIV Infections
  • co-formulated 25mg TAF/ 200mg FTC
  • Thika, Kenya
    Kenya Medical Research Institute - Partners in Health Research a
Jan 24, 2023

Ovarian Carcinoma Trial in New Haven (Sacituzumab govitecan)

Not yet recruiting
  • Ovarian Carcinoma
  • Sacituzumab govitecan
  • New Haven, Connecticut
    Smilow Cancer Hospital at Yale New Haven
Aug 31, 2023

HIV Trial in Houston (B/FTC/TAF, Current ART)

Terminated
Has Results
  • HIV Infections
  • Houston, Texas
    Thomas Street Health Center
Sep 1, 2022

Hepatitis C Trial in Lexington (PREP-C, Modified ECHO, Patient Telemedicine Questionnaire)

Completed
  • Hepatitis C
  • PREP-C
  • +2 more
  • Lexington, Kentucky
    University of Kentucky
Jan 31, 2023

Head Neck, Squamous Cell Carcinoma of Head and Neck Trial in Houston (Pembrolizumab, Magrolimab, cetuximab)

Not yet recruiting
  • Head Neck
  • Squamous Cell Carcinoma of Head and Neck
  • Houston, Texas
    M D Anderson Cancer Center
Sep 14, 2023

HIV/AIDS, Substance Use Disorders, Adherence, Medication Trial in Boylston (Digital pill, Truvada)

Completed
Has Results
  • HIV/AIDS
  • +2 more
  • Boylston, Massachusetts
    Fenway Health
Dec 20, 2022

Localized Muscle Invasive Bladder Urothelial Carcinoma, Muscle-Invasive Bladder Carcinoma Trial in Cleveland (Sacituzumab

Not yet recruiting
  • Localized Muscle Invasive Bladder Urothelial Carcinoma
  • Muscle-Invasive Bladder Carcinoma
  • Sacituzumab govitecan
  • Adaptive Radiotherapy
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Apr 18, 2023

Hiv Trial (DTG DT (6 x 5 mg), F/TAF TOS (3 x 60/7.5 mg))

Not yet recruiting
  • Hiv
  • DTG DT (6 x 5 mg)
  • F/TAF TOS (3 x 60/7.5 mg)
  • (no location specified)
Aug 8, 2022

Elimination of Hepatitis C Virus Among Users of Substances

Not yet recruiting
  • Hepatitis C in Substance Users
  • Sofosbuvir 400 MG / Velpatasvir 100 MG [Epclusa]
  • (no location specified)
Aug 14, 2022

Healthy Participants Trial in Groningen ([14C]-etrumadenant)

Completed
  • Healthy Participants
  • Groningen, NZ, Netherlands
    PRA Health Sciences (PRA) - Early Development Services (EDS)
Dec 6, 2022

Biliary Tract Carcinoma, Cholangiocarcinoma, Bile Duct Cancer Trial in Madison (Gemcitabine, Cisplatin, Zimberelimab)

Not yet recruiting
  • Biliary Tract Carcinoma
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin
Sep 15, 2023